China: Molecular Point-of-Care’s International Market to Watch

/by Daniel Granderson

Molecular point-of-care (mPOC) is a multi-billion dollar market with expanding international intrigue. Though the mPOC market is led by North America and Europe, the Asia-Pacific region makes up 10% of the market’s worldwide sales, with China positioned as a burgeoning power within the APAC. Kalorama Information, a leading medical market research firm, covers mPOC’s global […]

Read more

China Emerging as Vital Point of Care (POC) Market

/by Daniel Granderson

  Reforms in China, along with increasing incidence of cancer, diabetes, heart disease and infectious diseases such as HIV, hepatitis and STDs, provide new opportunities for point-of-care, advanced tests and molecular diagnostics, reports medical market research publisher Kalorama Information.   China’s potential as a point of care (POC) market was already growing when the coronavirus […]

Read more